CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Stephen D. Skaper  
Department of Pharmaceutical and Pharmacological Sciences
University of Padua
Padua
Italy

Back

Ahead of Print Article(s)

A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia

Volume:17
Charilaos Gerasimou , James N. Tsoporis, Nikolaos Siafakas, Erifili Hatziagelaki , Maria Kallergi , Sofia N. Chatziioannou, Thomas G. Parker , John Parissis, Vasileios Salpeas, Charalabos Papageorgiou and Emmanouil Rizos *

Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion

Volume:17
Zhe Gong, Jingrui Pan, Xiangpen Li, Hongxuan Wang, Lei He and Ying Peng*

Protective Effects of Crocetin on Depression-like Behavior Induced by Immobilization in Rat

Volume:17
Tahereh Farkhondeh, Saeed Samarghandian*, Fariborz Samini and Ali Rajabpour Sanati

Structure, Function and Interactions of Tau: Particular Focus on Potential Drug Targets for the Treatment of Tauopathies

Volume:17
Hojjat Borna, Kasim Assadoulahei, Gholamhossein Riazi, Asghar Beigi Harchegani and Alireza Shahriary*

Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity

Volume:17
Kai Wang, Weiming Sun, Linlin Zhang, Wei Guo, Jiachun Xu, Shuang Liu, Zhen Zhou and Yulian Zhang*

Protective Effect of Kaempferol on the Transgenic Drosophila Model of Alzheimer’s Disease

Volume:17
Tanveer Beg, Smita Jyoti, Falaq Naz, Rahul , Fahad Ali, Syed Kashif Ali, Ahmed Mohamed Reyad and Yasir Hasan Siddique*

Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke

Volume:17
Bogdan Catalin, O C Rogoveanu , Ionica Pirici, Tudor Adrian Balseanu, Adina Stan, Valerica Tudorica, Maria Balea , Ion Mindrila, Carmen Valeria Albu , Guleed Mohamed, Daniel Pirici* and Dafin Fior Muresanu

Cinnamon Polyphenol Extract Exerts Neuroprotective Activity in Traumatic Brain Injury in Male Mice

Volume:17
Burak Yulug*, Ertugrul Kilic, Serdar Altunay, Cenk Ersavas, Cemal Orhan, Arman Dalay, Nurhan Sahin, Mehmet Tuzcu, Vijaya Juturu and Kazim Sahin

Vitamin D’s Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence

Volume:17
Ahmad Saedisomeolia, Mahsa Samadi, Fatemeh Gholami, Marzieh Seyedi, Mohammad Effatpanah, Rezvan Hashemi, Siamand Anvari, Mina Abdolahi, Mahmoud Djalali and Niyaz Mohammadzadeh Honarvar*

Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene

Volume:17
Danillo Ramos Oliveira, Dayane Moreira Silva, Iziara Ferreira Florentino, Adriane de Brito, James Oluwagbamigbe Fajemiroye, Daiany Priscilla Bueno Silva, Fabio da Rocha, Elson Alves Costa and Pablinny Galdino De Carvalho*

Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases

Volume:17
Kin Yen Chia, Khuen Yen Ng, Rhun Yian Koh and Soi Moi Chye*

Lysosomal Potassium Channels: Potential Roles in Lysosomal Function and Neurodegenerative Diseases

Volume:17
Xinghua Feng*, Zhuangzhuang Zhao, Qian Li and Zhiyong Tan

The Yin and Yang of BK Channels in Epilepsy

Volume:17
Yudan Zhu, Shuzhang Zhang, Yijun Feng, Qian Xiao, Jiwei Cheng and Jie Tao*

K+ Channels of Müller Glial Cells in Retinal Disorders

Volume:17
Feng Gao, Linjie Xu, Yuan Zhao, Xinghuai Sun and Zhongfeng Wang*

Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies

Volume:16
A. R. Neelakandan and G. K. Rajanikant*

NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease

Volume:16
Chul Ju Hwang, Dong-Young Choi, Mi Hee Park and Jin Tae Hong*